Stock DXRX DIACEUTICS PLC
Add to a list
To use this feature you must be a member
Log inSign up

Company Diaceutics PLC

Equities

DXRX

GB00BJQTGV64

Business Support Services

Market Closed - London S.E.
Other stock markets
 09:05:08 02/05/2024 pm IST 		5-day change 1st Jan Change
99.5 GBX 0.00% Intraday chart for Diaceutics PLC -3.40% +14.37%
02/04 Roadside shares suspended; Adnams looks for funds AN
21/03 Diaceutics upgrades diagnositc commercialisation platform, DXRX AN

Business Summary

Diaceutics PLC is a United Kingdom-based company, which is a provider of technology and solutions. The Company provides pharma and biotech companies with an end-to-end commercialization solution for precision medicine through data analytics, scientific and advisory services enabled by its platform DXRX - The Diagnostics Network. The Company operates through three segments: Insight Solutions (Data), Engagement Solutions (Tech enabled services), and Advisory Services (Professional services). The Company’s DXRX - The Diagnostics Network is a diagnostic commercialization platform for precision medicine, integrating multiple pipelines of real-world diagnostic testing data from a global network of laboratories. It provides unrivalled access to multiple pipelines of real-world diagnostic testing data from a global network of laboratories. Its Tech Enabled Services offers clinical testing labs to provide enablement and educational services in novel biomarkers.

Number of employees: 151

Sales per Business

GBP in Million2021Weight2022Weight Delta
Platform - Insight Solutions
64.9 %
7 53.2 % 13 64.9 % +70.73%
Advisory Services
23.7 %
6 40.5 % 5 23.7 % -18.09%
Platform - Engagement Solutions
11.4 %
1 6.4 % 2 11.4 % +151.07%

Sales per region

GBP in Million2021Weight2022Weight Delta
North America
74.1 %
8 60.7 % 14 74.1 % +70.91%
Europe
13.8 %
4 26.0 % 3 13.8 % -25.59%
Asia and the Rest of the World
9.2 %
1 9.4 % 2 9.2 % +37.08%
United Kingdom
2.9 %
1 4.0 % 1 2.9 % +1.08%

Managers

Managers TitleAgeSince
Ryan Keeling CEO
 Chief Executive Officer 40 01/08/01
Nick Roberts DFI
 Director of Finance/CFO - 18/22/18
Julie Browne COO
 Chief Operating Officer - 15/22/15
Monica Salomeia ADM
 Chief Administrative Officer - -
Johnny Rice CTO
 Chief Tech/Sci/R&D Officer - 01/18/01
Peter Keeling BRD
 Director/Board Member 63 01/05/01
Gillian Shaw LAW
 General Counsel - -
Kevin Monaghan PRN
 Corporate Officer/Principal - -
Jillian Beggs PRN
 Corporate Officer/Principal - 01/21/01
Lee Rothwell PRN
 Corporate Officer/Principal - 01/18/01

Members of the board

Members of the board TitleAgeSince
Graham Paterson BRD
 Director/Board Member - 01/23/01
Deborah Davis CHM
 Chairman 61 04/21/04
Peter Keeling BRD
 Director/Board Member 63 01/05/01
Ryan Keeling CEO
 Chief Executive Officer 40 01/08/01
Michael Wort BRD
 Director/Board Member 73 14/19/14
Nick Roberts DFI
 Director of Finance/CFO - 18/22/18

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 84,705,551 55,442,991 ( 65.45 %) 0 65.45 %

Shareholders

NameEquities%Valuation
Peter Keeling
18.60 %
15,752,049 18.60 % 21 M p
Canaccord Genuity Wealth Ltd.
9.077 %
7,687,677 9.077 % 10 M p
Gresham House Asset Management Ltd. (Investment Management)
6.736 %
5,704,778 6.736 % 8 M p
Joh. Berenberg, Gossler & Co. KG (Investment Management)
6.405 %
5,425,207 6.405 % 7 M p
Danske Bank A/S (Investment Management)
6.131 %
5,192,960 6.131 % 7 M p
Universal-Investment-Gesellschaft mbH (Invt Mgmt)
4.734 %
4,009,764 4.734 % 5 M p
Gresham House Asset Management Ltd.
4.569 %
3,869,604 4.569 % 5 M p
Elizabeth Considine
3.674 %
3,112,169 3.674 % 4 M p
Herald Investment Management Ltd.
3.555 %
3,011,000 3.555 % 4 M p
Ryan Keeling
3.531 %
2,990,643 3.531 % 4 M p

Company contact information

Diaceutics Plc

Enterprise House 55-59 Adelaide Street

BT2 8FE, Belfast

+

http://www.diaceutics.com
address Diaceutics PLC(DXRX)

Group companies

NameCategory and Sector
Diaceutics Ireland Ltd.
Logo Diaceutics Ireland Ltd.

Diaceutics Ireland Ltd.

Medical/Nursing ServicesHealth Services

Diaceutics Ireland Ltd. provides diagnostic testing and data analytics services. Its services include diagnostic landscape, planning, commercialization, tracking, market research, and reimbursement. The company was founded by Peter Keeling in 2005 and is headquartered in Dundalk, Ireland.

Medical/Nursing Services

Sector

Industrials
Industrial & Commercial Services
Professional & Commercial Services
Business Support Services
Data Processing Services

Sales per Business

Sales per region

Ratings for Diaceutics PLC

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
0.995 GBP
Average target price
1.666 GBP
Spread / Average Target
+67.44%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Data Processing Services

1st Jan change Capi.
DIACEUTICS PLC Stock Diaceutics PLC
+14.37% 105M
VERRA MOBILITY CORPORATION Stock Verra Mobility Corporation
+4.58% 3.95B
WNS (HOLDINGS) LIMITED Stock WNS (Holdings) Limited
-33.69% 1.96B
COMPUTER AGE MANAGEMENT SERVICES LIMITED Stock Computer Age Management Services Limited
+24.73% 1.89B
BLS INTERNATIONAL SERVICES LIMITED Stock BLS International Services Limited
+9.52% 1.73B
KEHUA DATA CO., LTD. Stock Kehua Data Co., Ltd.
-4.23% 1.69B
SDIC INTELLIGENCE XIAMEN INFORMATION CO., LTD. Stock SDIC Intelligence Xiamen Information Co., Ltd.
-16.17% 1.59B
JMDC INC. Stock JMDC Inc.
-24.70% 1.34B
SHANGHAI @HUB CO.,LTD. Stock Shanghai @hub Co.,Ltd.
-4.99% 1.2B
FUJIAN START GROUP CO.LTD Stock Fujian Start Group Co.Ltd
-4.66% 1.05B
Data Processing Services
  1. Stock Market
  2. Equities
  3. DXRX Stock
  4. Company Diaceutics PLC